Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess Disease State Stability, Efficacy, and Tolerability in a Natalizumab to Dimethyl Fumarate Crossover Design

NCT01945359 is registered in ClinicalTrials.gov with Rocky Mountain MS Research Group, LLC as lead sponsor.

NCT NCT01945359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01945359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess Disease State Stability, Efficacy, and Tolerability in a Natalizumab to Dimethyl Fumarate Crossover Design
Lead sponsor
Rocky Mountain MS Research Group, LLC
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
June 30, 2015
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis